There is a consensus statement that there is no need to change drug treatment options between desmoid that develops with an APC mutation in the germ line (Gardner's syndrome) and desmoid that has a CTNNB1 mutation in sporadic cases2 based on the findings that both tumor types respond to drug treatment similarly11. Here, CTNNB1 is linked to Gardner syndrome.